FKBP-RAPAMYCIN INHIBITS A CYCLIN-DEPENDENT KINASE-ACTIVITY AND A CYCLIN D1-CDK ASSOCIATION IN EARLY G1 OF AN OSTEOSARCOMA CELL-LINE

被引:0
作者
ALBERS, MW
WILLIAMS, RT
BROWN, EJ
TANAKA, A
HALL, FL
SCHREIBER, SL
机构
[1] HARVARD UNIV, DEPT CHEM, CAMBRIDGE, MA 02138 USA
[2] UNIV SO CALIF, CHILDRENS HOSP LOS ANGELES, SCH MED, DIV ORTHOPED SURG, LOS ANGELES, CA 90089 USA
[3] UNIV SO CALIF, SCH PHARM, DEPT MOLEC PHARMACOL & TOXICOL, LOS ANGELES, CA 90054 USA
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Upon entering a cell the natural product rapamycin, like the structurally related immunosuppressant FK506, associates with members of the FKBP family of proteins. One or more of the resulting FKBP-rapamycin complexes blocks signaling pathways emanating from some growth factor receptors. Recently, the addition of rapamycin was shown to inhibit the phosphorylation and activation of a 70-kDa ribosomal S6 protein kinase, which normally occurs minutes after the activation of certain cytokine and growth factor receptors. We now report that rapamycin can be added 4 to 6 h after the addition of serum growth factors to quiescent human osteosarcoma cells and still arrest these cells in G1. This window of action correlates with the inducible appearance of a cyclin-dependent kinase (cdk) activity, and the induction of this activity is inhibited by the addition of rapamycin. Furthermore, p36cyclin D1 associates with this cdk protein complex in lysates of untreated cells, but does not associate with this cdk protein complex in lysates of rapamycin-treated cells. Together, these studies demonstrate that FKBP-rapamycin can modulate a cyclin-dependent kinase activity and a cyclin D1-cdk association during early G1 in MG-63 human osteosarcoma cells.
引用
收藏
页码:22825 / 22829
页数:5
相关论文
共 28 条
[1]  
AJCHENBAUM F, 1993, J BIOL CHEM, V268, P4113
[2]   PROBING IMMUNOSUPPRESSANT ACTION WITH A NONNATURAL IMMUNOPHILIN LIGAND [J].
BIERER, BE ;
SOMERS, PK ;
WANDLESS, TJ ;
BURAKOFF, SJ ;
SCHREIBER, SL .
SCIENCE, 1990, 250 (4980) :556-559
[3]   2 DISTINCT SIGNAL TRANSMISSION PATHWAYS IN LYMPHOCYTES-T ARE INHIBITED BY COMPLEXES FORMED BETWEEN AN IMMUNOPHILIN AND EITHER FK506 OR RAPAMYCIN [J].
BIERER, BE ;
MATTILA, PS ;
STANDAERT, RF ;
HERZENBERG, LA ;
BURAKOFF, SJ ;
CRABTREE, G ;
SCHREIBER, SL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (23) :9231-9235
[4]   INTERLEUKIN-2 STIMULATION OF P70 S6 KINASE-ACTIVITY IS INHIBITED BY THE IMMUNOSUPPRESSANT RAPAMYCIN [J].
CALVO, V ;
CREWS, CM ;
VIK, TA ;
BIERER, BE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (16) :7571-7575
[5]  
CARBONAROHALL D, 1993, ONCOGENE, V8, P1649
[6]   RAPAMYCIN FKBP SPECIFICALLY BLOCKS GROWTH-DEPENDENT ACTIVATION OF AND SIGNALING BY THE 70 KD S6 PROTEIN-KINASES [J].
CHUNG, J ;
KUO, CJ ;
CRABTREE, GR ;
BLENIS, J .
CELL, 1992, 69 (07) :1227-1236
[7]   PHOSPHORYLATION INDEPENDENT ACTIVATION OF HUMAN CYCLIN-DEPENDENT KINASE-2 BY CYCLIN-A INVITRO [J].
CONNELLCROWLEY, L ;
SOLOMON, MJ ;
WEI, N ;
HARPER, JW .
MOLECULAR BIOLOGY OF THE CELL, 1993, 4 (01) :79-92
[8]   PHYSICAL INTERACTION OF THE RETINOBLASTOMA PROTEIN WITH HUMAN D-CYCLINS [J].
DOWDY, SF ;
HINDS, PW ;
LOUIE, K ;
REED, SI ;
ARNOLD, A ;
WEINBERG, RA .
CELL, 1993, 73 (03) :499-511
[9]  
DUMONT FJ, 1990, J IMMUNOL, V144, P1418
[10]   CDK2 ENCODES A 33-KDA CYCLIN-A-ASSOCIATED PROTEIN-KINASE AND IS EXPRESSED BEFORE CDC2 IN THE CELL-CYCLE [J].
ELLEDGE, SJ ;
RICHMAN, R ;
HALL, FL ;
WILLIAMS, RT ;
LODGSON, N ;
HARPER, JW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (07) :2907-2911